Avastin and Troponin increased - a phase IV clinical study of FDA data

Summary:

Troponin increased is reported as a side effect among people who take Avastin (bevacizumab), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Fluorouracil, and have Lung cancer - non-small cell.

The phase IV clinical study analyzes which people have Troponin increased when taking Avastin. It is created by eHealthMe based on reports of 75,729 people who have side effects when taking Avastin from the FDA, and is updated regularly.

What is Avastin?

Avastin has active ingredients of bevacizumab. It is often used in high blood cholesterol. eHealthMe is studying from 76,365 Avastin users. Check the latest studies of Avastin.

What is Troponin increased?

Troponin increased is found to be associated with 701 drugs and 816 conditions by eHealthMe. Check the latest studies of Troponin increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

75,729 people reported to have side effects when taking Avastin.
Among them, 34 people (0.04%) have Troponin increased.

Among these 34 people:

How long have people been on Avastin when they have Troponin increased? *

What is the gender of people who have Troponin increased when taking Avastin? *

female: 30.3 %
male: 69.7 %

What is the age of people who have Troponin increased when taking Avastin? *

What are other drugs people take besides Avastin? *

What are other side effects people have besides Troponin increased? *

Weakness: 11 people, 32.35%
Blood Creatine Phosphokinase Increased: 9 people, 26.47%
Hypotension (abnormally low blood pressure): 8 people, 23.53%
Heart Attack: 8 people, 23.53%
Pleural Effusion (water on the lungs): 6 people, 17.65%
Dyspnea (difficult or laboured breathing): 5 people, 14.71%
Fainting (loss of consciousness and postural tone): 5 people, 14.71%
Renal Impairment (severely reduced kidney function): 5 people, 14.71%
Pneumonia: 5 people, 14.71%
Chest Pain: 5 people, 14.71%

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 6 people, 17.65%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 5 people, 14.71%
Rectal Cancer (cancer of rectum): 4 people, 11.76%
Colon Cancer: 3 people, 8.82%
Peripheral T-Cell Lymphoma Unspecified (peripheral t-cell cancer unspecified): 1 person, 2.94%
Ovarian Cancer Recurrent (reoccurrence of ovary cancer): 1 person, 2.94%
Non-Small Cell Lung Cancer Stage Ii: 1 person, 2.94%
Neuralgia (pain in one or more nerves): 1 person, 2.94%
Lung Carcinoma Cell Type Unspecified Stage 0 (the lung cancer has not spread beyond the inner lining of the lung): 1 person, 2.94%
Laryngeal Papilloma (a virus infection of larynx by pilloma virus): 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Avastin and have Troponin increased?

- Check whether Troponin increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Avastin:

Avastin (76,365 reports)

Browse all side effects of Avastin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Troponin increased:

Troponin increased (701 drugs)

Browse all the conditions that are associated with Troponin increased:

Troponin increased (816 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bevacizumab (the active ingredients of Avastin) and Avastin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.